Certainty after CRISPR, a CRISPR Medicine News Webinar supported by COBO Technologies and Samplix
Recent developments in gene-editing technologies have enabled researchers to delete, insert and change regions in genomes down to the single base level. These developments show great potential in gene editing-based next generation gene therapies. However, the primary outcome after nuclease-based gene editing is insertions and deletions (InDels) at the targeted locus in the genome. Importantly, recent observations have shown that in addition to the formation of InDels at the desired site, unexpected outcomes also occur after gene editing. For registration and more details about this webinar, please click here.